Ask a Question
Sign In
Don’t have an account?
  • Therapeutic Area
  • Content
Bayer Logo RGB
BAYERMEDYour Scientific Resource Portal
  • CHRONIC KIDNEY DISEASE
  • Disease & Awareness
  • Events
  • Learning Materials
  • Medical Literature
  • CONTRACEPTION
  • Learning Materials
  • Clinical Tools
  • HEART FAILURE
  • Events
  • Medical Literature
  • HEMOPHILIA
  • Learning Materials
  • MENOPAUSE
  • Awareness
  • Learning Materials
  • OPHTHALMOLOGY
  • Learning Materials
  • Medical Literature
  • PROSTATE CANCER
  • Clinical Tools
  • Events
  • Learning Materials
  • Medical Literature
  • CLINICAL TOOLS
  • Contraception
  • Prostate Cancer
  • DISEASE & AWARENESS
  • Chronic Kidney Disease
  • Menopause
  • EVENTS
  • Chronic Kidney Disease
  • Heart Failure
  • Prostate Cancer
  • LEARNING MATERIALS
  • Chronic Kidney Disease
  • Contraception
  • Hemophilia
  • Menopause
  • Ophthalmology
  • Prostate Cancer
  • MEDICAL LITERATURE
  • Chronic Kidney Disease
  • Heart Failure
  • Ophthalmology
  • Prostate Cancer
    EN - EnglishFR - French
closesearch
Recent Searches
    You Are About To Leave The Current Site

    Click 'OK' to proceed or 'Cancel' to stay on the current page.

    Clinical Tools Recent Updates

    PCS-X
    Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
    AlphaBet
    Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer (AlphaBet)
    DASL-HiCaP
    Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)
    RAVENS
    RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (RAVENS)

    Product Monograph

    Radium-223 Teaser Card FR
    Monographie de produit du radium-223
    Obtenez la version la plus récente de la monographie de produit du radium-223.
    Darolutamide Teaser Card FR
    Monographie de produit du darolutamide
    Obtenez la version la plus récente de la monographie de produit du darolutamide.

    Darolutamide Clinical Trials

    DASL-HiCaP
    DASL-HiCaP
    Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)
    ARASTEP
    ARASTEP
    A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and ...
    DAROL
    DAROL
    A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has...
    PCS-X Teaser Card
    PCS-X
    Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

    Radium-223 Clinical Trials

    View more
    DORA Teaser Card
    DORA
    A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
    Radient Teaser Card
    RADIANT
    Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatme...
    RAVENS
    RAVENS
    RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (RAVENS)
    RAPSON teaser card
    RAPSON
    Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (RAPSON)

    Actinium-225 Clinical Trials

    PAnTHA (225Ac-PSMA-Trillium)
    PAnTHA (225Ac-PSMA-Trillium)
    First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (...
    Pelgi (225Ac-macropa-pelgifatamab)
    Pelgi (225Ac-macropa-pelgifatamab)
    A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves In...